Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of a topical formulation containing MIA (Melanoma Inhibitory Activity) - Inhibitory peptides in a case of recalcitrant vitiligo in combination with UV exposure.
Hernandez Navarro S, Segura Tejedor J, Bajona Roig M, Luisetto R, Fedrigo M, Castellani C, Angelini A, Alaibac M, Bordignon M. Hernandez Navarro S, et al. Among authors: bordignon m. Medicine (Baltimore). 2022 Nov 18;101(46):e31833. doi: 10.1097/MD.0000000000031833. Medicine (Baltimore). 2022. PMID: 36401489 Free PMC article.
Is Sézary syndrome a true primary cutaneous lymphoma?
Alaibac M, Pigozzi B, Bordignon M. Alaibac M, et al. Among authors: bordignon m. Int J Dermatol. 2008 Nov;47(11):1195-6. doi: 10.1111/j.1365-4632.2008.03641.x. Int J Dermatol. 2008. PMID: 18986460 No abstract available.
Immunosuppression and melanocyte proliferation.
Zattra E, Fortina AB, Bordignon M, Piaserico S, Alaibac M. Zattra E, et al. Among authors: bordignon m. Melanoma Res. 2009 Apr;19(2):63-8. doi: 10.1097/CMR.0b013e328322fc20. Melanoma Res. 2009. PMID: 19194340 Review.
Anetoderma in cutaneous marginal-zone B-cell lymphoma.
Zattra E, Pigozzi B, Bordignon M, Marino F, Chiarion-Sileni V, Alaibac M. Zattra E, et al. Among authors: bordignon m. Clin Exp Dermatol. 2009 Dec;34(8):e945-8. doi: 10.1111/j.1365-2230.2009.03593.x. Epub 2009 Sep 22. Clin Exp Dermatol. 2009. PMID: 19778307
Bullous pemphigoid during long-term TNF-alpha blocker therapy.
Bordignon M, Belloni-Fortina A, Pigozzi B, Tarantello M, Alaibac M. Bordignon M, et al. Dermatology. 2009;219(4):357-8. doi: 10.1159/000243805. Epub 2009 Oct 1. Dermatology. 2009. PMID: 19797890 Free article. No abstract available.
Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up.
Belloni-Fortina A, Faggion D, Pigozzi B, Peserico A, Bordignon M, Baldo V, Alaibac M. Belloni-Fortina A, et al. Among authors: bordignon m. Clin Dev Immunol. 2009;2009:187864. doi: 10.1155/2009/187864. Epub 2009 Dec 10. Clin Dev Immunol. 2009. PMID: 20049340 Free PMC article.
52 results